glp 1 class medications What are GLP-1s? GLP-1 medications are not just

Retatrutide: A Triple Agonist with Unprecedented Efficacy Retatrutide (LY3437943) is a novel triple incretin agonist that simultaneously targets the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors

D.tefnescuV

doi: 10.1177/17562864241281903, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar] 101

Before we talk about what this means, let's look at the story of how these medications were created and how much they cost

That approach eliminates the need to keep them cold, or to have someone trained to administer the injections

Crohns Colitis 15 , 17201736 (2021)